• 1805 Citations
  • 25 h-Index
1993 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 1805 Citations
  • 25 h-Index
  • 113 Article
  • 2 Review article
  • 1 Short survey
2020

Gefitinib alone versus gefitinib plus chemotherapy for non–small-cell lung cancer with mutated epidermal growth factor receptor: NEJ009 study

North-East Japan Study Group, 2020, In : Journal of Clinical Oncology. 38, 2, p. 115-123 9 p.

Research output: Contribution to journalArticle

Key prognostic factors for EGFR-mutated non-adenocarcinoma lung cancer patients in the Japanese Joint Committee of Lung Cancer Registry Database

Kobayashi, K., Soejima, K., Fukunaga, K., Shintani, Y., Sekine, I., Shukuya, T., Takayama, K., Inoue, A., Okamoto, I., Kiura, K., Takahashi, K., Yamamoto, N., Takiguchi, Y., Miyaoka, E., Okumura, M. & Yoshino, I., 2020 Aug, In : Lung Cancer. 146, p. 236-243 8 p.

Research output: Contribution to journalArticle

Successful Retreatment Using Pembrolizumab for Non–small-cell Lung Cancer After Severe Immune-related Hepatitis: A Case Report

Kobayashi, K., Nakachi, I., Mitsuishi, A., Arai, D., Sakurai, K., Masaki, K., Chiyotani, A., Takahashi, H., Tahara, T. & Soejima, K., 2020 Jan, In : Clinical Lung Cancer. 21, 1, p. e30-e32

Research output: Contribution to journalArticle

2019

A phase II trial of induction of erlotinib followed by cytotoxic chemotherapy for EGFR mutation-positive non-squamous non-small cell lung cancer patients

Tani, T., Naoki, K., Yasuda, H., Arai, D., Ishioka, K., Ohgino, K., Yoda, S., Nakayama, S., Satomi, R., Terai, H., Ikemura, S., Sato, T. & Soejima, K., 2019 Nov 1, In : Cancer Chemotherapy and Pharmacology. 84, 5, p. 1065-1071 7 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)

Brain metastases in oncogene-driven non-small cell lung cancer

Nishino, M., Soejima, K. & Mitsudomi, T., 2019 Jan 1, In : Translational Lung Cancer Research. 8, p. S298-S307

Research output: Contribution to journalReview article

Effect of FGF/FGFR pathway blocking on lung adenocarcinoma and its cancer-associated fibroblasts

Hegab, A. E., Ozaki, M., Kameyama, N., Gao, J., Kagawa, S., Yasuda, H., Soejima, K., Yin, Y., Guzy, R. D., Nakamura, Y., Ornitz, D. M. & Betsuyaku, T., 2019 Oct 1, In : Journal of Pathology. 249, 2, p. 193-205 13 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)

Efficacy of afatinib or osimertinib plus cetuximab combination therapy for non-small-cell lung cancer with EGFR exon 20 insertion mutations

Hasegawa, H., Yasuda, H., Hamamoto, J., Masuzawa, K., Tani, T., Nukaga, S., Hirano, T., Kobayashi, K., Manabe, T., Terai, H., Ikemura, S., Kawada, I., Naoki, K. & Soejima, K., 2019 Jan 1, In : Lung Cancer. 127, p. 146-152 7 p.

Research output: Contribution to journalArticle

9 Citations (Scopus)

Long-lasting response to nivolumab for a patient with lynch syndrome-associated lung adenocarcinoma

Masuzawa, K., Asakura, T., Ikemura, S., Yasuda, H., Kawada, I., Takaoka, S., Hayashi, Y., Nakajima, T., Arai, M., Fukunaga, K. & Soejima, K., 2019, In : JCO Precision Oncology. 3, p. 74-78 5 p.

Research output: Contribution to journalArticle

Molecular dynamics simulation-guided drug sensitivity prediction for lung cancer with rare EGFR mutations

Ikemura, S., Yasuda, H., Matsumoto, S., Kamada, M., Hamamoto, J., Masuzawa, K., Kobayashi, K., Manabe, T., Arai, D., Nakachi, I., Kawada, I., Ishioka, K., Nakamura, M., Namkoong, H., Naoki, K., Ono, F., Araki, M., Kanada, R., Ma, B., Hayashi, Y. & 8 others, Mimaki, S., Yoh, K., Kobayashi, S. S., Kohno, T., Okuno, Y., Goto, K., Tsuchihara, K. & Soejima, K., 2019 May 14, In : Proceedings of the National Academy of Sciences of the United States of America. 116, 20, p. 10025-10030 6 p.

Research output: Contribution to journalArticle

Open Access
7 Citations (Scopus)

Monomer preference of EGFR tyrosine kinase inhibitors influences the synergistic efficacy of combination therapy with cetuximab

Oashi, A., Yasuda, H., Kobayashi, K., Tani, T., Hamamoto, J., Masuzawa, K., Manabe, T., Terai, H., Ikemura, S., Kawada, I., Naoki, K. & Soejima, K., 2019 Jan 1, In : Molecular cancer therapeutics. 18, 9, p. 1593-1601 9 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Multicenter study of zoledronic acid administration in non-small-cell lung cancer patients with bone metastasis: Thoracic oncology research group (TORG) 1017

Nakahara, Y., Hosomi, Y., Shibuya, M., Mitsufuji, H., Katagiri, M., Naoki, K., Soejima, K., Nogami, N., Nagase, S., Nishikawa, M., Minato, K., Takiguchi, Y., Seki, N., Yamada, K., Seto, T. & Okamoto, H., 2019 Oct, In : Molecular and Clinical Oncology. 11, 4, p. 349-353 5 p.

Research output: Contribution to journalArticle

2018

Comparison of detection methods of EGFR T790M mutations using plasma, serum, and tumor tissue in EGFR-TKI-resistant non-small cell lung cancer

Kobayashi, K., Naoki, K., Manabe, T., Masuzawa, K., Hasegawa, H., Yasuda, H., Kawada, I., Soejima, K. & Betsuyaku, T., 2018 Jun 6, In : OncoTargets and Therapy. 11, p. 3335-3343 9 p.

Research output: Contribution to journalArticle

10 Citations (Scopus)

Egfr-mutant non-small cell lung cancer accompanied by transient asymptomatic pulmonary opacities successfully treated with “stop-and-go” osimertinib

Kobayashi, K., Naoki, K., Kuroda, A., Yasuda, H., Kawada, I., Soejima, K. & Betsuyaku, T., 2018 Jan 1, In : Internal Medicine. 57, 7, p. 1007-1010 4 p.

Research output: Contribution to journalArticle

Intermittent exposure to cigarette smoke increases lung tumors and the severity of emphysema more than continuous exposure

Kameyama, N., Chubachi, S., Hegab, A. E., Yasuda, H., Kagawa, S., Tsutsumi, A., Fukunaga, K., Shimoda, M., Kanai, Y., Soejima, K. & Betsuyaku, T., 2018 Aug 1, In : American Journal of Respiratory Cell and Molecular Biology. 59, 2, p. 179-188 10 p.

Research output: Contribution to journalArticle

8 Citations (Scopus)

Pharmacological and structural characterizations of naquotinib, a novel third-generation EGFR tyrosine kinase inhibitor, in EGFR-mutated non–small cell lung cancer

Hirano, T., Yasuda, H., Hamamoto, J., Nukaga, S., Masuzawa, K., Kawada, I., Naoki, K., Niimi, T., Mimasu, S., Sakagami, H., Soejima, K. & Betsuyaku, T., 2018 Apr 1, In : Molecular Cancer Therapeutics. 17, 4, p. 740-750 11 p.

Research output: Contribution to journalArticle

9 Citations (Scopus)

Prognostic Understanding at Diagnosis and Associated Factors in Patients with Advanced Lung Cancer and Their Caregivers

Sato, T., Soejima, K., Fujisawa, D., Takeuchi, M., Arai, D., Nakachi, I., Naoki, K., Kawada, I., Yasuda, H., Ishioka, K., Nukaga, S., Kobayashi, K., Masaki, K., Inoue, T., Hikima, K., Nakamura, M., Ohgino, K., Oyamada, Y., Funatsu, Y., Terashima, T. & 5 others, Miyao, N., Sayama, K., Saito, F., Sakamaki, F. & Betsuyaku, T., 2018 Jan 1, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalArticle

2 Citations (Scopus)

Prospective exosome-focused translational research for afatinib study of non-small cell lung cancer patients expressing EGFR (EXTRA study)

Okuma, Y., Morikawa, K., Tanaka, H., Yokoyama, T., Itani, H., Horiuchi, K., Nakagawa, H., Takahashi, N., Bessho, A., Soejima, K., Kishi, K., Togashi, A., Kanai, Y., Ueda, K., Horimoto, K., Matsutani, N. & Seki, N., 2018 Jan 1, (Accepted/In press) In : Thoracic Cancer.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Real-world Efficacy and Safety of Nivolumab for Advanced Non-Small-cell Lung Cancer: A Retrospective Multicenter Analysis

Kobayashi, K., Nakachi, I., Naoki, K., Satomi, R., Nakamura, M., Inoue, T., Tateno, H., Sakamaki, F., Sayama, K., Terashima, T., Koh, H., Abe, T., Nishino, M., Arai, D., Yasuda, H., Kawada, I., Soejima, K. & Betsuyaku, T., 2018 Jan 1, (Accepted/In press) In : Clinical Lung Cancer.

Research output: Contribution to journalArticle

11 Citations (Scopus)

Secondary brain neoplasm after stereotactic radiosurgery in patients with metastatic non-small cell lung cancer

Nukaga, S., Naoki, K., Yasuda, H., Kawada, I., Ohara, K., Soejima, K. & Betsuyaku, T., 2018 Jan 1, In : Internal Medicine. 57, 16, p. 2383-2387 5 p.

Research output: Contribution to journalArticle

Targeted Therapy-induced Facial Skin Toxicities: Impact on Quality of Life in Cancer Patients

Yagasaki, K., Komatsu, H., Soejima, K., Naoki, K., Kawada, I., Yasuda, H. & Hamamoto, Y., 2018 Apr 1, In : Asia-Pacific Journal of Oncology Nursing. 5, 2, p. 172-177 6 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

The FGF2 aptamer inhibits the growth of FGF2-FGFR pathway driven lung cancer cells

Hamamoto, J., Yasuda, H., Nonaka, Y., Fujiwara, M., Nakamura, Y., Soejima, K. & Betsuyaku, T., 2018 Jan 1, (Accepted/In press) In : Biochemical and Biophysical Research Communications.

Research output: Contribution to journalArticle

3 Citations (Scopus)

Tumor associated macrophages support the growth of FGF9-induced lung adenocarcinoma by multiple mechanisms

Hegab, A. E., Ozaki, M., Kagawa, S., Hamamoto, J., Yasuda, H., Naoki, K., Soejima, K., Yin, Y., Kinoshita, T., Yaguchi, T., Kawakami, Y., Ornitz, D. M. & Betsuyaku, T., 2018 May 1, In : Lung Cancer. 119, p. 25-35 11 p.

Research output: Contribution to journalArticle

5 Citations (Scopus)
2017

Amplification of EGFR wild-type alleles in non-small cell lung cancer cells confers acquired resistance to mutation-selective EGFR tyrosine kinase inhibitors

Nukaga, S., Yasuda, H., Tsuchihara, K., Hamamoto, J., Masuzawa, K., Kawada, I., Naoki, K., Matsumoto, S., Mimaki, S., Ikemura, S., Goto, K., Betsuyaku, T. & Soejima, K., 2017 Apr 15, In : Cancer Research. 77, 8, p. 2078-2089 12 p.

Research output: Contribution to journalArticle

50 Citations (Scopus)

A prospective cohort study of patients with non-squamous non-small cell lung cancer treated with bevacizumab

Naoki, K., Takeda, Y., Soejima, K., Arai, D., Naka, G. O., Nagase, S., Arimura, K., Kanemura, T., Ohhira, T. & Ikeda, N., 2017 May, In : Oncology Letters. 13, 5, p. 3285-3290 6 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)

Characterization of the efficacies of osimertinib and nazartinib against cells expressing clinically relevant epidermal growth factor receptor mutations

Masuzawa, K., Yasuda, H., Hamamoto, J., Nukaga, S., Hirano, T., Kawada, I., Naoki, K., Soejima, K. & Betsuyaku, T., 2017 Jan 1, In : Oncotarget. 8, 62, p. 105479-105491 13 p.

Research output: Contribution to journalArticle

17 Citations (Scopus)

Clinical and pathological characteristics of EGFR mutation in operable early-stage lung adenocarcinoma

Yotsukura, M., Yasuda, H., Shigenobu, T., Kaseda, K., Masai, K., Hayashi, Y., Hishida, T., Ohtsuka, T., Naoki, K., Soejima, K., Betsuyaku, T. & Asamura, H., 2017 Jul 1, In : Lung Cancer. 109, p. 45-51 7 p.

Research output: Contribution to journalArticle

14 Citations (Scopus)

Effects of the common polymorphism in the human aldehyde dehydrogenase 2 (ALDH2) gene on the lung

Kuroda, A., Hegab, A. E., Jingtao, G., Yamashita, S., Hizawa, N., Sakamoto, T., Yamada, H., Suzuki, S., Ishii, M., Namkoong, H., Asakura, T., Ozaki, M., Yasuda, H., Hamamoto, J., Kagawa, S., Soejima, K. & Betsuyaku, T., 2017 Apr 21, In : Respiratory Research. 18, 1, 69.

Research output: Contribution to journalArticle

5 Citations (Scopus)

Non-small cell lung cancer PC-9 cells exhibit increased sensitivity to gemcitabine and vinorelbine upon acquiring resistance to EGFR-tyrosine kinase inhibitors

Hamamoto, J., Yasuda, H., Aizawa, K., Nishino, M., Nukaga, S., Hirano, T., Kawada, I., Naoki, K., Betsuyaku, T. & Soejima, K., 2017, In : Oncology Letters. 14, 3, p. 3559-3565 7 p.

Research output: Contribution to journalArticle

5 Citations (Scopus)

Osimertinib for EGFR T790M mutation-positive non-small cell lung cancer

Soejima, K., Yasuda, H. & Hirano, T., 2017 Jan 2, In : Expert Review of Clinical Pharmacology. 10, 1, p. 31-38 8 p.

Research output: Contribution to journalArticle

16 Citations (Scopus)

Overcoming EGFR bypass signal-induced acquired resistance to ALK tyrosine kinase inhibitors in ALK-translocated lung cancer

Miyawaki, M., Yasuda, H., Tani, T., Hamamoto, J., Arai, D., Ishioka, K., Ohgino, K., Nukaga, S., Hirano, T., Kawada, I., Naoki, K., Hayashi, Y., Betsuyaku, T. & Soejima, K., 2017 Jan 1, In : Molecular Cancer Research. 15, 1, p. 106-114 9 p.

Research output: Contribution to journalArticle

20 Citations (Scopus)

Radiologic features of precancerous areas of the lungs in chronic obstructive pulmonary disease

Keio COPD Comorbidity Research Group, 2017 May 30, In : International Journal of COPD. 12, p. 1613-1624 12 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)

Variant CD44 expression is enriching for a cell population with cancer stem cell-like characteristics in human lung adenocarcinoma

Nishino, M., Ozaki, M., Hegab, A. E., Hamamoto, J., Kagawa, S., Arai, D., Yasuda, H., Naoki, K., Soejima, K., Saya, H. & Betsuyaku, T., 2017 Jun 1, In : Journal of Cancer. 8, 10, p. 1774-1785 12 p.

Research output: Contribution to journalArticle

11 Citations (Scopus)
2016

Activation of EGFR bypass signaling by TGFa overexpression induces acquired resistance to alectinib in ALK-translocated lung cancer cells

Tani, T., Yasuda, H., Hamamoto, J., Kuroda, A., Arai, D., Ishioka, K., Ohgino, K., Miyawaki, M., Kawada, I., Naoki, K., Hayashi, Y., Betsuyaku, T. & Soejima, K., 2016 Jan 1, In : Molecular cancer therapeutics. 15, 1, p. 162-171 10 p.

Research output: Contribution to journalArticle

27 Citations (Scopus)

Development of an S-1 dosage formula based on renal function by a prospective pharmacokinetic study

Booka, E., Imamura, C. K., Takeuchi, H., Hamamoto, Y., Gomi, D., Mizukami, T., Ichiyama, T., Tateishi, K., Takahashi, T., Kawakubo, H., Soejima, K., Boku, N., Tanigawara, Y. & Kitagawa, Y., 2016 Jul 1, In : Gastric Cancer. 19, 3, p. 876-886 11 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)
2015

A phase II study of biweekly paclitaxel and carboplatin in elderly patients with advanced non-small cell lung cancer

Soejima, K., Naoki, K., Ishioka, K., Nakamura, M., Nakatani, M., Kawada, I., Watanabe, H., Nakachi, I., Yasuda, H., Satomi, R., Nakayama, S., Yoda, S., Ikemura, S., Terai, H., Sato, T., Ohgino, K., Arai, D., Tani, T., Kuroda, A., Nishino, M. & 1 others, Betsuyaku, T., 2015 Mar, In : Cancer Chemotherapy and Pharmacology. 75, 3, p. 513-519 7 p.

Research output: Contribution to journalArticle

7 Citations (Scopus)

A Phase II study of S-1 and irinotecan combination therapy in previously treated patients with advanced non-small cell lung cancer

Ikemura, S., Naoki, K., Yasuda, H., Kawada, I., Yoda, S., Terai, H., Sato, T., Ishioka, K., Arai, D., Ohgino, K., Kamata, H., Miyata, J., Kabata, H., Betsuyaku, T. & Soejima, K., 2015 Apr 1, In : Japanese journal of clinical oncology. 45, 4, p. 356-361 6 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)

Characterization of the cell of origin and propagation potential of the fibroblast growth factor 9-induced mouse model of lung adenocarcinoma

Arai, D., Hegab, A. E., Soejima, K., Kuroda, A., Ishioka, K., Yasuda, H., Naoki, K., Kagawa, S., Hamamoto, J., Yin, Y., Ornitz, D. M. & Betsuyaku, T., 2015 Mar 1, In : Journal of Pathology. 235, 4, p. 593-605 13 p.

Research output: Contribution to journalArticle

18 Citations (Scopus)

Dry pleurisy complicating solitary pulmonary nodules caused by Mycobacterium avium: A case report

Asakura, T., Ishii, M., Haraguchi, M., Kamiyama, I., Kono, M., Sakamaki, H., Emoto, K., Hayashi, Y., Sugiura, H., Kawada, I., Soejima, K., Namkoong, H., Tasaka, S., Hasegawa, N. & Betsuyaku, T., 2015 Oct 26, (Accepted/In press) In : Journal of Medical Case Reports.

Research output: Contribution to journalArticle

4 Citations (Scopus)

Fatal fulminant pneumonia caused by methicillin-sensitive staphylococcus aureus negative for major high-virulence factors following influenza B virus infection

Masaki, K., Ishii, M., Anraku, M., Namkoong, H., Miyakawa, R., Nakajima, T., Fukunaga, K., Naoki, K., Tasaka, S., Soejima, K., Sayama, K., Sugita, K., Iwata, S., Cui, L., Hanaki, H., Hasegawa, N. & Betsuyaku, T., 2015 Jul 14, In : American Journal of Case Reports. 16, p. 454-458 5 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

FOXD1 expression is associated with poor prognosis in non-small cell lung cancer

Nakayama, S., Soejima, K., Yasuda, H., Yoda, S., Satomi, R., Ikemura, S., Terai, H., Sato, T., Yamaguchi, N., Hamamoto, J., Arai, D., Ishioka, K., Ohgino, K., Naoki, K. & Betsuyaku, T., 2015 Jan 1, In : Anticancer research. 35, 1, p. 261-268 8 p.

Research output: Contribution to journalArticle

18 Citations (Scopus)

In vitro modeling to determine mutation specificity of EGFR tyrosine kinase inhibitors against clinically relevant EGFR mutants in non-small-cell lung cancer

Hirano, T., Yasuda, H., Tani, T., Hamamoto, J., Oashi, A., Ishioka, K., Arai, D., Nukaga, S., Miyawaki, M., Kawada, I., Naoki, K., Costa, D. B., Kobayashi, S. S., Betsuyaku, T. & Soejima, K., 2015 Jan 1, In : Oncotarget. 6, 36, p. 38789-38803 15 p.

Research output: Contribution to journalArticle

58 Citations (Scopus)

Long-term exposure to gefitinib induces acquired resistance through DNA methylation changes in the EGFR-mutant PC9 lung cancer cell line

Terai, H., Soejima, K., Yasuda, H., Sato, T., Naoki, K., Ikemura, S., Arai, D., Ohgino, K., Ishioka, K., Hamamoto, J., Kanai, Y. & Betsuyaku, T., 2015 Jan 1, In : International journal of oncology. 46, 1, p. 430-436 7 p.

Research output: Contribution to journalArticle

7 Citations (Scopus)

Methylation-induced downregulation of TFPI-2 causes TMPRSS4 overexpression and contributes to oncogenesis in a subset of non-small-cell lung carcinoma

Hamamoto, J., Soejima, K., Naoki, K., Yasuda, H., Hayashi, Y., Yoda, S., Nakayama, S., Satomi, R., Terai, H., Ikemura, S., Sato, T., Arai, D., Ishioka, K., Ohgino, K. & Betsuyaku, T., 2015 Jan 1, In : Cancer science. 106, 1, p. 34-42 9 p.

Research output: Contribution to journalArticle

12 Citations (Scopus)

Mimicking the niche of lung epithelial stem cells and characterization of several effectors of their in vitro behavior

Hegab, A. E., Arai, D., Gao, J., Kuroda, A., Yasuda, H., Ishii, M., Naoki, K., Soejima, K. & Betsuyaku, T., 2015 Jul 1, In : Stem Cell Research. 15, 1, p. 109-121 13 p.

Research output: Contribution to journalArticle

32 Citations (Scopus)

Multiple roles of extracellular fibroblast growth factors in lung cancer cells

Suzuki, T., Yasuda, H., Funaishi, K., Arai, D., Ishioka, K., Ohgino, K., Tani, T., Hamamoto, J., Ohashi, A., Naoki, K., Betsuyaku, T. & Soejima, K., 2015 Jan 1, In : International journal of oncology. 46, 1, p. 423-429 7 p.

Research output: Contribution to journalArticle

11 Citations (Scopus)

Prognostic implication of PTPRH hypomethylation in non-small cell lung cancer

Sato, T., Soejima, K., Arai, E., Hamamoto, J., Yasuda, H., Arai, D., Ishioka, K., Ohgino, K., Naoki, K., Kohno, T., Tsuta, K., Watanabe, S. I., Kanai, Y. & Betsuyaku, T., 2015 Sep 1, In : Oncology reports. 34, 3, p. 1137-1145 9 p.

Research output: Contribution to journalArticle

8 Citations (Scopus)

The reasons for triple therapy in stable COPD patients in Japanese clinical practice

Miyazaki, M., Nakamura, H., Takahashi, S., Chubachi, S., Sasaki, M., Haraguchi, M., Terai, H., Ishii, M., Fukunaga, K., Tasaka, S., Soejima, K., Asano, K. & Betsuyaku, T., 2015 Jun 4, In : International Journal of COPD. 10, p. 1053-1059 7 p.

Research output: Contribution to journalArticle

17 Citations (Scopus)
2014

Claudin-1 is a novel target of miR-375 in non-small-cell lung cancer

Yoda, S., Soejima, K., Hamamoto, J., Yasuda, H., Nakayama, S., Satomi, R., Terai, H., Ikemura, S., Sato, T., Naoki, K. & Betsuyaku, T., 2014 Jan 1, In : Lung Cancer. 85, 3, p. 366-372 7 p.

Research output: Contribution to journalArticle

27 Citations (Scopus)

Epigenetic clustering of lung adenocarcinomas based on DNA methylation profiles in adjacent lung tissue: Its correlation with smoking history and chronic obstructive pulmonary disease

Sato, T., Arai, E., Kohno, T., Takahashi, Y., Miyata, S., Tsuta, K., Watanabe, S. I., Soejima, K., Betsuyaku, T. & Kanai, Y., 2014 Jul 15, In : International Journal of Cancer. 135, 2, p. 319-334 16 p.

Research output: Contribution to journalArticle

34 Citations (Scopus)

Expression of fibroblast growth factor 9 is associated with poor prognosis in patients with resected non-small cell lung cancer

Ohgino, K., Soejima, K., Yasuda, H., Hayashi, Y., Hamamoto, J., Naoki, K., Arai, D., Ishioka, K., Sato, T., Terai, H., Ikemura, S., Yoda, S., Tani, T., Kuroda, A. & Betsuyaku, T., 2014 Jan 1, In : Lung Cancer. 83, 1, p. 90-96 7 p.

Research output: Contribution to journalArticle

28 Citations (Scopus)